DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,967,704 | -29.3% | 240,800 | +1.1% | 0.00% | -20.0% |
Q2 2023 | $7,026,331 | +48.6% | 238,100 | +16.0% | 0.01% | +66.7% |
Q1 2023 | $4,727,808 | -18.5% | 205,200 | -1.6% | 0.00% | -25.0% |
Q4 2022 | $5,798,385 | -7.4% | 208,500 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $6,264,000 | +5.7% | 204,100 | +1.3% | 0.00% | 0.0% |
Q2 2022 | $5,927,000 | -1.8% | 201,400 | +7.3% | 0.00% | +33.3% |
Q1 2022 | $6,038,000 | -22.1% | 187,700 | +8.1% | 0.00% | -40.0% |
Q4 2021 | $7,747,000 | -11.8% | 173,700 | -0.2% | 0.01% | -16.7% |
Q3 2021 | $8,783,000 | -34.8% | 174,100 | +1.3% | 0.01% | -25.0% |
Q2 2021 | $13,476,000 | +32.5% | 171,800 | -3.5% | 0.01% | +14.3% |
Q1 2021 | $10,170,000 | -30.5% | 178,100 | +1.9% | 0.01% | -30.0% |
Q4 2020 | $14,641,000 | +127.5% | 174,800 | -2.7% | 0.01% | +100.0% |
Q3 2020 | $6,435,000 | +50.8% | 179,600 | +1.8% | 0.01% | +25.0% |
Q2 2020 | $4,268,000 | +101.3% | 176,500 | +45.7% | 0.00% | +100.0% |
Q1 2020 | $2,120,000 | +2.0% | 121,100 | +1.5% | 0.00% | 0.0% |
Q4 2019 | $2,078,000 | +16.6% | 119,300 | +2.6% | 0.00% | 0.0% |
Q3 2019 | $1,782,000 | -25.2% | 116,300 | +1.3% | 0.00% | -33.3% |
Q2 2019 | $2,383,000 | -8.8% | 114,800 | +2.0% | 0.00% | 0.0% |
Q1 2019 | $2,612,000 | +16.0% | 112,500 | +3.2% | 0.00% | 0.0% |
Q4 2018 | $2,252,000 | -3.3% | 109,000 | +1.8% | 0.00% | 0.0% |
Q3 2018 | $2,328,000 | +363.7% | 107,100 | +225.5% | 0.00% | +200.0% |
Q2 2018 | $502,000 | – | 32,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |